Oracle's Backlog Diversification Offers Limited Relief Against Debt and Cash Flow Concerns

What happened

Oracle's $664 billion backlog has become the focal point for bulls, with the Motley Fool noting that OpenAI now accounts for less than half of that total, but debt levels and high bond yields continue to unnerve investors. The DeepValue master report shows that as of May 2026, Oracle's remaining performance obligations were $638 billion, yet only about 12% were expected to convert to revenue within twelve months, with FY2026 free cash flow deeply negative at -$23.7 billion. The shift away from OpenAI concentration is a modest positive, but it does not solve Oracle's core problem: booked AI demand is not translating into near-term cash generation fast enough to offset massive capital expenditures. Oracle still plans to raise approximately $40 billion in FY2027, including a $20 billion at-the-market equity program, and credit markets are already pricing in balance-sheet risk. Investors should treat the backlog headlines with skepticism and focus on quarterly revenue conversion and customer prepayments, not the absolute size of contracted obligations.

Implication

The article's emphasis on backlog diversification offers a counterpoint to the bearish debt narrative, but it does not address the fundamental issue of Oracle's negative free cash flow and slow revenue recognition. Investors should monitor upcoming quarterly results for cloud growth within the guided 58–64% range and any increase in customer prepayments or BYOH structures, which would signal better funding economics. Until 12-month RPO conversion rises meaningfully above 12% or operating cash flow expands faster than capex, the stock lacks a margin of safety at current levels. The planned $20 billion ATM issuance remains a key overhang, as material usage would dilute existing shareholders and confirm that debt markets are insufficient to fund the buildout. The attractive entry remains near $135, and a breakdown below that would warrant reassessment, while a sustained move above $185 would only be justified by proven cash conversion.

Thesis delta

No change to the WAIT thesis. The article provides incremental color on backlog composition but does not alter the core concerns around slow near-term conversion and negative free cash flow. The investment case still hinges on whether Oracle can turn its long-dated AI backlog into cash quickly enough to support its capital-intensive expansion.